硬膜外联合全麻与单纯全麻术后长期生存:随机试验随访
该研究对五项医院既往随机试验中60至90岁行大型非心脏胸腹部手术患者进行长期随访,比较硬膜外联合全麻加术后硬膜外镇痛与单纯全麻加术后静脉镇痛对长期生存的影响。长期分析纳入1,712例(92%为癌症手术),中位随访66个月,结果显示联合硬膜外全麻未改善总生存、癌症特异生存、无复发生存及无事件生存。
要点
- 老年大型胸腹部手术中,硬膜外联合全麻未改善长期总生存。
- 癌症特异生存、无复发生存及无事件生存两组间均无差异。
- 两种麻醉方式可依据患者与临床医师偏好合理选择。
核心结论
- 在老年大型胸腹部手术患者中,硬膜外联合全麻加硬膜外镇痛未改善总体或癌症特异长期死亡率,也未改善无复发生存。
- 两种麻醉方式均可依据患者和临床医师偏好合理选择。
研究设计与样本
- 本文为既往在五家医院开展的一项随机试验的长期随访研究。
- 患者年龄60至90岁,拟行大型非心脏胸部和腹部手术,随机分为硬膜外联合全麻加术后硬膜外镇痛组或单纯全麻加术后静脉镇痛组。
- 原试验入组并随机1,802例,长期分析纳入1,712例,其中92%为癌症手术。
- 主要结局为术后总生存,次要结局包括癌症特异生存、无复发生存和无事件生存。
主要发现
- 中位随访66个月(四分位距61至80)。
- 联合硬膜外全麻组853例中355例(42%)死亡,单纯全麻组859例中326例(38%)死亡:校正风险比1.07,95%CI 0.92至1.24,P=0.408。
- 癌症特异生存:联合硬膜外全麻组327/853(38%),单纯全麻组292/859(34%):校正风险比1.09,95%CI 0.93至1.28,P=0.290。
- 无复发生存:联合硬膜外全麻组401/853(47%),单纯全麻组389/859(45%):校正风险比0.97,95%CI 0.84至1.12,P=0.692。
- 无事件生存:联合硬膜外全麻组466/853(55%),单纯全麻组450/859(52%):校正风险比0.99,95%CI 0.86至1.12,P=0.815。
临床怎么用
- 对于老年大型胸腹部手术患者,不应以改善长期生存为目的常规选择硬膜外联合全麻加硬膜外镇痛。
- 麻醉方式选择可综合患者情况和临床医师偏好,两种方式均可合理选用。
局限性
- 原文摘要未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Experimental and observational research suggests that combined epidural-general anesthesia may improve long-term survival after cancer surgery by reducing anesthetic and opioid consumption and by blunting surgery-related inflammation. This study therefore tested the primary hypothesis that combined epidural-general anesthesia improves long-term survival in elderly patients. METHODS: This article presents a long-term follow-up of patients enrolled in a previous trial conducted at five hospitals. Patients aged 60 to 90 yr and scheduled for major noncardiac thoracic and abdominal surgeries were randomly assigned to either combined epidural-general anesthesia with postoperative epidural analgesia or general anesthesia alone with postoperative intravenous analgesia. The primary outcome was overall postoperative survival. Secondary outcomes included cancer-specific, recurrence-free, and event-free survival. RESULTS: Among 1,802 patients who were enrolled and randomized in the underlying trial, 1,712 were included in the long-term analysis; 92% had surgery for cancer. The median follow-up duration was 66 months (interquartile range, 61 to 80). Among patients assigned to combined epidural-general anesthesia, 355 of 853 (42%) died compared with 326 of 859 (38%) deaths in patients assigned to general anesthesia alone: adjusted hazard ratio, 1.07; 95% CI, 0.92 to 1.24; P = 0.408. Cancer-specific survival was similar with combined epidural-general anesthesia (327 of 853 [38%]) and general anesthesia alone (292 of 859 [34%]): adjusted hazard ratio, 1.09; 95% CI, 0.93 to 1.28; P = 0.290. Recurrence-free survival was 401 of 853 [47%] for patients who had combined epidural-general anesthesia versus 389 of 859 [45%] with general anesthesia alone: adjusted hazard ratio, 0.97; 95% CI, 0.84 to 1.12; P = 0.692. Event-free survival was 466 of 853 [55%] in patients who had combined epidural-general anesthesia versus 450 of 859 [52%] for general anesthesia alone: adjusted hazard ratio, 0.99; 95% CI, 0.86 to 1.12; P = 0.815. CONCLUSIONS: In elderly patients having major thoracic and abdominal surgery, combined epidural-general anesthesia with epidural analgesia did not improve overall or cancer-specific long-term mortality. Nor did epidural analgesia improve recurrence-free survival. Either approach can therefore reasonably be selected based on patient and clinician preference.
引用
- Du YT, Li YW, Zhao BJ, et al. Long-term Survival after Combined Epidural-General Anesthesia or General Anesthesia Alone: Follow-up of a Randomized Trial. Anesthesiology. 2021. PMID: 34195784. doi:10.1097/ALN.0000000000003835
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。